Rabia Gurses Ozden is Chief Medical Officer of Adverum Biotechnologies, Inc.. Currently has a direct ownership of 8,125 shares of ADVM, which is worth approximately $38,268. The most recent transaction as insider was on Feb 25, 2025, when has been sold 8,125 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.13K
n/a 3M change
n/a 12M change
Total Value Held $38,268

Rabia Gurses Ozden Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 25 2025
BUY
Grant, award, or other acquisition
-
8,125 Added 50.0%
8,125 Common Stock

Also insider at

OCUL
OCULAR THERAPEUTIX, INC Healthcare
RGO

Rabia Gurses Ozden

Chief Medical Officer
Bedford, MA

Track Institutional and Insider Activities on ADVM

Follow Adverum Biotechnologies, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADVM shares.

Notify only if

Insider Trading

Get notified when an Adverum Biotechnologies, Inc. insider buys or sells ADVM shares.

Notify only if

News

Receive news related to Adverum Biotechnologies, Inc.

Track Activities on ADVM